Both FOXP1 and p65 expression are adverse risk factors in diffuse large B-cell lymphoma: a retrospective study in China

CR Hu, JH Wang, R Wang, Q Sun, LB Chen - Acta histochemica, 2013 - Elsevier
The purpose of this study was to investigate the clinical significance of FOXP1 and p65
expression in diffuse large B-cell lymphoma (DLBCL). Immunohistochemistry was performed
to determine the expression of FOXP1 and p65 protein in 92 DLBCL tissues and analyze
their correlations with clinicopathological features or prognosis of patients. The survival was
assessed by the Kaplan–Meier method and proportional hazards model. Results showed
that positive FOXP1 expression was detected in 68 (73.9%) cases and positive p65 …